Fellowship · Jamaica Plain, MA
Sponsored by Mass General Brigham
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
The New England journal of medicine · 2022 · 277 citations · Emily Ruiz
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
JAMA oncology · 2022 · 123 citations · Abigail Waldman
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 69 citations · Emily Ruiz, Abigail Waldman
How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations.
NPJ digital medicine · 2025 · 28 citations · Emily Ruiz
riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinoma.
Journal of the American Academy of Dermatology · 2025 · 20 citations · Nina Ran, Emily Ruiz
Mohs Surgery vs Wide Local Excision in Primary High-Stage Cutaneous Squamous Cell Carcinoma.
JAMA dermatology · 2025 · 18 citations · Emily Ruiz
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
The Lancet. Oncology · 2023 · 72 citations · Emily Ruiz
Impact of immunosuppression on cutaneous squamous cell carcinoma outcomes.
Journal of the American Academy of Dermatology · 2026 · 8 citations · Emily Ruiz, Nina Ran